Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock subscribed but not issued
Additional paid-in capital
Accumulated deficit
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2021   334,030,348 0      
Beginning balance at Dec. 31, 2021 $ 36,299 $ 334 $ 0 $ 134,920 $ (97,392) $ (1,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock subscribed but not issued (in shares)     2,717      
Common stock subscribed but not issued 2   $ 2      
Exercise of stock options (in shares)   10,000        
Exercise of stock options 3     3    
Conversion of promissory notes to equity (in shares)   1,142,858        
Conversion of promissory notes to stock 400 $ 1   399    
Common stock issued to settle obligations (in shares)   375,000        
Common stock issued to settle obligations 274 $ 1   273    
Distributions to non-controlling interests (101)         (101)
Stock-based compensation 2,469     2,469    
Net (loss) income 4,241       4,188 53
Ending balance (in shares) at Mar. 31, 2022   335,558,206 2,717      
Ending balance at Mar. 31, 2022 43,587 $ 336 $ 2 138,064 (93,204) (1,611)
Beginning balance (in shares) at Dec. 31, 2021   334,030,348 0      
Beginning balance at Dec. 31, 2021 36,299 $ 334 $ 0 134,920 (97,392) (1,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 8,859          
Ending balance (in shares) at Sep. 30, 2022   339,270,387 74,581      
Ending balance at Sep. 30, 2022 51,877 $ 339 $ 41 141,652 (88,675) (1,480)
Beginning balance (in shares) at Dec. 31, 2021   334,030,348 0      
Beginning balance at Dec. 31, 2021 36,299 $ 334 $ 0 134,920 (97,392) (1,563)
Ending balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Ending balance at Dec. 31, 2022 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Beginning balance (in shares) at Mar. 31, 2022   335,558,206 2,717      
Beginning balance at Mar. 31, 2022 $ 43,587 $ 336 $ 2 138,064 (93,204) (1,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares) 2,717   (2,717)      
Issuance of subscribed shares $ 0   $ (2) 2    
Cashless exercise of stock options (in shares) 200,000          
Cashless exercise of warrants (in shares) 234,961          
Release of shares under stock grants (in shares)   354,221        
Shares issued as purchase consideration - business acquisition (in shares)   2,343,750        
Shares issued as purchase consideration - business acquisition $ 1,500 $ 3   1,497    
Purchase of minority interests in certain of the Company’s subsidiaries (2,000)     (2,165)   165
Distributions to non-controlling interests (83)         (83)
Stock-based compensation 2,553     2,553    
Net (loss) income 1,896       1,823 73
Ending balance (in shares) at Jun. 30, 2022   338,693,855 0      
Ending balance at Jun. 30, 2022 47,453 $ 339 $ 0 139,951 (91,381) (1,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock subscribed but not issued (in shares)     74,581      
Common stock subscribed but not issued 41   $ 41      
Exercise of stock options (in shares)   45,000        
Exercise of stock options 7     7    
Common stock issued to settle obligations (in shares)   531,532        
Common stock issued to settle obligations 363     363    
Distributions to non-controlling interests (40)         (40)
Stock-based compensation 1,331     1,331    
Net (loss) income 2,722       2,706 16
Ending balance (in shares) at Sep. 30, 2022   339,270,387 74,581      
Ending balance at Sep. 30, 2022 51,877 $ 339 $ 41 141,652 (88,675) (1,480)
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares)   70,000 (70,000)      
Issuance of subscribed shares 0   $ (39) 39    
Common stock subscribed but not issued (in shares)     5,025      
Common stock subscribed but not issued 0   $ 2      
Warrants issued in connection with debt 5,454     5,454    
Shares issued as purchase consideration - business acquisition (in shares)   6,580,390        
Shares issued as purchase consideration - business acquisition 2,994 $ 7   2,987    
Common stock issued under licensing agreement (in shares)   1,793        
Common stock issued under licensing agreement 1     1    
Distributions to non-controlling interests (34)         (34)
Stock-based compensation 206     206    
Net (loss) income (664)       (645) (19)
Ending balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Ending balance at Mar. 31, 2023 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 $ 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares) 5,025          
Exercise of stock options (in shares) 487,752          
Net (loss) income $ (5,868)          
Ending balance (in shares) at Sep. 30, 2023   375,871,958 0      
Ending balance at Sep. 30, 2023 79,862 $ 376 $ 0 170,922 (89,786) (1,650)
Beginning balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Beginning balance at Mar. 31, 2023 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares)   5,025 (5,025)      
Issuance of subscribed shares 0   $ (2) 2    
Exercise of stock options (in shares)   157,752        
Exercise of stock options 35     35    
Release of shares under stock grants (in shares)   349,999        
Release of shares under stock grants 0 $ 1   (1)    
Conversion of preferred stock to common stock (in shares)   21,383,040        
Conversion of preferred stock to common stock 15,823 $ 21   15,802    
Purchase of minority interests in certain of the Company's subsidiaries (in shares)   450,000        
Purchase of minority interests in certain of the Company’s subsidiaries 0 $ 1   4   (5)
Common stock issued to settle obligations (in shares)   400,000        
Common stock issued to settle obligations 160     160    
Common stock issued under licensing agreement (in shares)   1,290        
Common stock issued under licensing agreement 0     0    
Common stock issued to purchase property and equipment (in shares)   740,741        
Common stock issued to purchase property and equipment 300 $ 1   299    
Distributions to non-controlling interests (47)         (47)
Stock-based compensation 299     299    
Net (loss) income (935)       (958) 23
Ending balance (in shares) at Jun. 30, 2023   371,614,758 0      
Ending balance at Jun. 30, 2023 80,904 $ 372 $ 0 167,652 (85,527) (1,593)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   330,000        
Exercise of stock options 74     74    
Conversion of preferred stock to common stock (in shares)   3,921,670        
Conversion of preferred stock to common stock 2,902 $ 4   2,898    
Common stock issued under licensing agreement (in shares)   5,530        
Common stock issued under licensing agreement 2     2    
Distributions to non-controlling interests (47)         (47)
Stock-based compensation 296     296    
Net (loss) income (4,269)       (4,259) (10)
Ending balance (in shares) at Sep. 30, 2023   375,871,958 0      
Ending balance at Sep. 30, 2023 $ 79,862 $ 376 $ 0 $ 170,922 $ (89,786) $ (1,650)